WELLS FARGO & COMPANY/MN - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$179,823
-29.2%
78,184
+12.4%
0.00%
Q2 2023$253,894
+38.6%
69,560
+35.5%
0.00%
Q1 2023$183,233
+33.6%
51,326
+6.7%
0.00%
Q4 2022$137,145
+204.8%
48,121
+140.5%
0.00%
Q3 2022$45,000
-10.0%
20,010
+0.1%
0.00%
Q2 2022$50,000
+16.3%
19,990
+129.7%
0.00%
Q1 2022$43,000
-78.5%
8,701
-50.7%
0.00%
Q4 2021$200,000
+1233.3%
17,647
+1664.7%
0.00%
Q3 2021$15,000
+25.0%
1,0000.0%0.00%
Q2 2021$12,000
-86.5%
1,000
-86.4%
0.00%
Q1 2021$89,000
-86.5%
7,341
-86.0%
0.00%
Q4 2020$658,000
-17.2%
52,617
-0.3%
0.00%
Q3 2020$795,000
-41.8%
52,781
-5.4%
0.00%
Q2 2020$1,367,000
+154.6%
55,765
+47.3%
0.00%
Q1 2020$537,000
+8.3%
37,862
+21.1%
0.00%
Q4 2019$496,000
+118.5%
31,266
+16.0%
0.00%
Q3 2019$227,000
-7.0%
26,945
-0.7%
0.00%
Q2 2019$244,000
-8.3%
27,147
-21.0%
0.00%
Q1 2019$266,000
+55.6%
34,355
-5.6%
0.00%
Q4 2018$171,000
-5.5%
36,410
+82.7%
0.00%
Q3 2018$181,000
-21.6%
19,930
+2.3%
0.00%
Q2 2018$231,000
+220.8%
19,486
+282.5%
0.00%
Q1 2018$72,0005,0940.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders